Accueil   Diary - News   All news PRAGMA awared 1st prize from UK charity Action on Hearing Loss

PRAGMA awared 1st prize from UK charity Action on Hearing Loss

copy-Logo-Tagline-grand

PRAGMA  Therapeutics awarded  first  prize  and £300,000  from UK  charity action  on hearing loss to develop new drugs to treat hearing loss.

 

 


PRAGMA  Therapeutics  SAS,  a  leading  biopharmaceutical company in the field of stress and trauma-related disorders, announced today that it has received a Translational Research Initiative for Hearing (TRIH) award from the charity Action on Hearing Loss to develop novel small molecule drugs for the treatment of Sensorineural Hearing Lossin both civilian and military patient populations.

 


To this end, PRAGMA has established an international collaboration with  world-renowned  Professor  Robert  Frisina,  Director of  the  Global  Center  for  Hearing  &  Speech Research  at the  University  of South Florida, and  principal  investigator to  perform  efficacy  studies  in  translational animal models of hearing loss

 

Read the press release

 

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree